Nintedanib
FDA approves Ofev to treat idiopathic pulmonary fibrosis
10/15/2014
The U.S. Food and Drug Administration today approved Ofev (nintedanib) for the treatment of idiopathic pulmonary fibrosis (IPF).
read at
see synthesis
http://newdrugapprovals.org/2014/05/21/in-battle-of-ipf-drugs-bis-nintedanib-impresses/
Filed under: FDA 2014 Tagged: FDA 2014, Food and Drug Administration, idiopathic pulmonary fibrosis, ipf, Nintedanib, Ofev
